{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:36:38Z","timestamp":1790796998976,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T00:00:00Z","timestamp":1687824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T00:00:00Z","timestamp":1687824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100008545","name":"Asociaci\u00f3n Pablo Ugarte","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008545","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-023-03251-0","type":"journal-article","created":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T06:02:57Z","timestamp":1687845777000},"page":"278-287","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Measurable residual disease study through three different methods can anticipate relapse and guide early interventions in childhood acute lymphoblastic leukemia"],"prefix":"10.1007","volume":"26","author":[{"given":"Eduardo","family":"Ramos Elbal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis","family":"Fuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A.","family":"Campillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Mar\u00eda","family":"Galera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar Berm\u00fadez","family":"Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Esther","family":"Llinares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Plaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helios","family":"Mart\u00ednez Banaclocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Antonio","family":"Gali\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Blanquer Blanquer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Victoria","family":"Mart\u00ednez S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Muro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2472-5893","authenticated-orcid":false,"given":"Alfredo","family":"Minguela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,27]]},"reference":[{"issue":"16","key":"3251_CR1","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1056\/NEJMra1400972","volume":"373","author":"SP Hunger","year":"2015","unstructured":"Hunger SP, Mullighan CG. Acute lymphoblastic leukemia in children. New Eng J Med. 2015;373(16):1541\u201352.","journal-title":"New Eng J Med"},{"issue":"27","key":"3251_CR2","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1200\/JCO.2014.59.1636","volume":"33","author":"CH Pui","year":"2015","unstructured":"Pui CH, Hunger SP, Pieters R, Schrappe M, Biondi A, Vora A, et al. Childhood acute lymphoblastic leukemia: progress through collaboration. J Clin Oncol. 2015;33(27):2938\u201348.","journal-title":"J Clin Oncol"},{"issue":"2","key":"3251_CR3","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1093\/rpd\/ncn289","volume":"132","author":"M Schrappe","year":"2008","unstructured":"Schrappe M. Risk-adapted stratification and treatment of childhood acute lymphoblastic leukemia. Radiat Prot Dosim. 2008;132(2):130\u20133.","journal-title":"Radiat Prot Dosim"},{"issue":"3","key":"3251_CR4","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1182\/blood-2006-07-037093","volume":"109","author":"T Raff","year":"2007","unstructured":"Raff T, G\u00f6kbuget N, L\u00fcschen S, Reutzel R, Ritgen M, Irmer S, et al. Molecular relapse in adult standard-risk ALL patients detected by prospective MRD monitoring during and after maintenance treatment: data from the GMALL 06\/99 and 07\/03 trials. Blood. 2007;109(3):910\u20135.","journal-title":"Blood"},{"issue":"26","key":"3251_CR5","doi-asserted-by":"publisher","first-page":"3996","DOI":"10.1182\/blood-2015-03-580027","volume":"125","author":"JJM van Dongen","year":"2015","unstructured":"van Dongen JJM, van der Velden VHJ, Br\u00fcggemann M, Orfao A. Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies. Blood. 2015;125(26):3996\u20134009.","journal-title":"Blood"},{"key":"3251_CR6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/2162-3619-3-16","volume":"3","author":"JS Woo","year":"2014","unstructured":"Woo JS, Alberti MO, Tirado CA. Chidlhood B-acute lymphoblastic leukemia: a genetic update. Exp Hematol Oncol. 2014;3:16 (eCollection 2014).","journal-title":"Exp Hematol Oncol"},{"issue":"6","key":"3251_CR7","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nrclinonc.2015.38","volume":"12","author":"KG Roberts","year":"2015","unstructured":"Roberts KG, Mullighan CG. Genomics in acute lymphoblastic leukemia: insights and treatment implications. Nat Rev Clin Oncol. 2015;12(6):344\u201357.","journal-title":"Nat Rev Clin Oncol"},{"issue":"26","key":"3251_CR8","doi-asserted-by":"publisher","first-page":"3977","DOI":"10.1182\/blood-2015-02-580043","volume":"125","author":"SP Hunger","year":"2015","unstructured":"Hunger SP, Mullighan CG. Redefining ALL classification: toward detecting high-risk ALL and implementing precision medicine. Blood. 2015;125(26):3977\u201387.","journal-title":"Blood"},{"issue":"6","key":"3251_CR9","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1182\/blood-2006-08-040436","volume":"109","author":"AV Moorman","year":"2007","unstructured":"Moorman AV, Richards SM, Robinson HM, Strefford JC, Gibson BES, Kinsey SE, et al. Prognosis of children with acute lymphoblastic leukemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21). Blood. 2007;109(6):2327\u201330.","journal-title":"Blood"},{"issue":"5","key":"3251_CR10","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1038\/leu.2013.317","volume":"28","author":"CJ Harrison","year":"2014","unstructured":"Harrison CJ, Moorman AV, Schwab C, Carroll AJ, Raetz EA, Devidas M, et al. An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome. Leukemia. 2014;28(5):1015\u201321.","journal-title":"Leukemia"},{"issue":"2","key":"3251_CR11","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S1470-2045(08)70339-5","volume":"10","author":"ML Den Boer","year":"2009","unstructured":"Den Boer ML, van Slegtenhorst M, De Menezes RX, Cheok MH, Buijs-Gladdines JG, Peters ST, et al. A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study. Lancet Oncol. 2009;10(2):125\u201334.","journal-title":"Lancet Oncol"},{"issue":"12","key":"3251_CR12","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","volume":"371","author":"KG Roberts","year":"2014","unstructured":"Roberts KG, Li Y, Payne-Turner D, Harvey RC, Yang YL, Pei D, et al. Targetable kinase activating lesions in Ph-like acute lymphoblastic leukemia. N Engl J Med. 2014;371(12):1005\u201315.","journal-title":"N Engl J Med"},{"issue":"3","key":"3251_CR13","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1016\/j.bbmt.2019.09.022","volume":"26","author":"Z Warraich","year":"2020","unstructured":"Warraich Z, Tenneti P, Thai T, Hubben A, Amin H, McBride A, et al. Relapse prevention with tyrosine kinase inhibitors after allogeneic transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia: a systematic review. Biol Blood Marrow Transplant. 2020;26(3):e55\u201364.","journal-title":"Biol Blood Marrow Transplant"},{"key":"3251_CR14","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al. Classification of tumours of haematopoietic and lymphoid tissues. Lyon, France: International Agency for Research on Cancer; 2008."},{"key":"3251_CR15","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon, France: International Agency for Research on Cancer; 2017."},{"issue":"10","key":"3251_CR16","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.3390\/cancers13102294","volume":"13","author":"MV Mart\u00ednez-S\u00e1nchez","year":"2021","unstructured":"Mart\u00ednez-S\u00e1nchez MV, Fuster JL, Campillo JA, Galera AM, Berm\u00fadez-Cort\u00e9s M, Llinares ME, et al. Expression of NK cell receptor ligands on leukemic cell is associated with the outcome of childhood acute leukemia. Cancers (Basel). 2021;13(10):2294.","journal-title":"Cancers (Basel)"},{"issue":"9","key":"3251_CR17","first-page":"4438","volume":"11","author":"A Minguela","year":"2021","unstructured":"Minguela A, Vasco-Mogorr\u00f3n MA, Campillo JA, Caba\u00f1as V, Remigia MJ, Berenguer M. Predictive value of 1q21 gain in multiple myeloma is strongly dependent on concurrent cytogenetic abnormalities and first-line treatment. Am J Cancer Res. 2021;11(9):4438\u201354.","journal-title":"Am J Cancer Res"},{"issue":"20","key":"3251_CR18","first-page":"6885","volume":"22","author":"X Qin","year":"2018","unstructured":"Qin X, Zhang MY, Liu WJ. Application of minimal residual disease monitoring in pediatric patients with acute lymphoblastic leukemia. Eur Rev Med Pharmacol Sci. 2018;22(20):6885\u201395.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"6","key":"3251_CR19","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s13312-020-1855-1","volume":"57","author":"S Agrwal","year":"2020","unstructured":"Agrwal S, Sahi PK. National comprehensive cancer network guidelines for pediatric acute lymphoblastic leukemia. Indian Pediatr. 2020;57(6):561\u20134.","journal-title":"Indian Pediatr"},{"issue":"16","key":"3251_CR20","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1182\/bloodadvances.2021004234","volume":"5","author":"L Muffly","year":"2021","unstructured":"Muffly L, Sundaram V, Chen C, Yurkiewcz I, Kuo E, Burnash S, et al. Concordance of peripheral blood and bone marrow measurable residual disease in adult lymphoblastic leukemia. Blood Adv. 2021;5(16):3147\u201351.","journal-title":"Blood Adv"},{"issue":"12","key":"3251_CR21","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1182\/blood-2017-09-801498","volume":"131","author":"GJ Schuurhuis","year":"2018","unstructured":"Schuurhuis GJ, Heuser M, Freeman S, B\u00e9n\u00e9 MC, Buccisano F, Cloos J, et al. Minimal\/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party. Blood. 2018;131(12):1275\u201391.","journal-title":"Blood"},{"issue":"9","key":"3251_CR22","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1038\/s41375-019-0496-7","volume":"33","author":"M Br\u00fcggemann","year":"2019","unstructured":"Br\u00fcggemann M, Kotrov\u00e1 M, Knecht H, Bartram J, Boudjogrha M, Bystry V, et al. Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation study. Leukemia. 2019;33(9):2241\u201353.","journal-title":"Leukemia"},{"issue":"5","key":"3251_CR23","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1182\/blood.2022017003","volume":"141","author":"M Svaton","year":"2023","unstructured":"Svaton M, Skotnicova A, Reznickova L, Rennerova A, Valova T, Kotrova M, et al. NGS better discriminates true MRD positivity for the risk stratification of childhood ALL treated on an MRD-based protocol. Blood. 2023;141(5):529\u201333.","journal-title":"Blood"},{"key":"3251_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-022-03042-z","author":"E Ramos Elbal","year":"2023","unstructured":"Ramos Elbal E, Fuster JL, Campillo JA, Galera AM, Berm\u00fadez Cort\u00e9s M, Llinares E, et al. Measurable residual disease study through three different methods can anticipate relapse and guide pre-emptive therapy in childhood acute lymphoblastic leukemia. Clin Transl Oncol. 2023. https:\/\/doi.org\/10.1007\/s12094-022-03042-z. (Online ahead of print).","journal-title":"Clin Transl Oncol"},{"issue":"2","key":"3251_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2174\/138920107780487465","volume":"8","author":"J Styczynski","year":"2007","unstructured":"Styczynski J. Drug resistance in childhood acute myeloid leukemia. Curr Pharm Biotechnol. 2007;8(2):59\u201375.","journal-title":"Curr Pharm Biotechnol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-023-03251-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-023-03251-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-023-03251-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T09:33:50Z","timestamp":1704188030000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-023-03251-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,27]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["3251"],"URL":"https:\/\/doi.org\/10.1007\/s12094-023-03251-0","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,27]]},"assertion":[{"value":"20 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was performed in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all patients (and\/or their parents) in accordance with the Declaration of Helsinki.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}